Creative Planning Has $394,000 Holdings in Amedisys, Inc. (NASDAQ:AMED)

Creative Planning boosted its stake in Amedisys, Inc. (NASDAQ:AMED) by 7.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,295 shares of the health services provider’s stock after buying an additional 295 shares during the quarter. Creative Planning’s holdings in Amedisys were worth $394,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in the business. Banque Cantonale Vaudoise bought a new position in Amedisys in the first quarter valued at about $60,000. Bridge City Capital LLC grew its stake in Amedisys by 0.8% in the first quarter. Bridge City Capital LLC now owns 29,861 shares of the health services provider’s stock valued at $2,752,000 after purchasing an additional 231 shares in the last quarter. Principal Financial Group Inc. boosted its stake in shares of Amedisys by 2.6% during the 1st quarter. Principal Financial Group Inc. now owns 122,845 shares of the health services provider’s stock worth $11,321,000 after acquiring an additional 3,074 shares during the period. BNP Paribas Financial Markets boosted its stake in shares of Amedisys by 111.7% during the 1st quarter. BNP Paribas Financial Markets now owns 12,050 shares of the health services provider’s stock worth $1,111,000 after acquiring an additional 6,358 shares during the period. Finally, Texas Permanent School Fund Corp lifted its holdings in Amedisys by 1.4% during the 1st quarter. Texas Permanent School Fund Corp now owns 28,560 shares of the health services provider’s stock worth $2,632,000 after purchasing an additional 381 shares during the last quarter. Institutional investors own 94.36% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the company. William Blair cut Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Deutsche Bank Aktiengesellschaft lowered Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price objective on the stock. in a research report on Monday, July 29th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $101.00 price objective on shares of Amedisys in a research report on Thursday, July 25th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $100.67.

Amedisys Stock Down 0.3 %

Shares of NASDAQ:AMED opened at $96.44 on Thursday. The company has a market capitalization of $3.15 billion, a price-to-earnings ratio of -150.69, a P/E/G ratio of 1.89 and a beta of 0.78. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16. The business’s 50-day moving average is $97.20 and its 200-day moving average is $95.31. Amedisys, Inc. has a 1 year low of $89.55 and a 1 year high of $98.95.

Amedisys (NASDAQ:AMED) last posted its quarterly earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.10. The business had revenue of $591.19 million for the quarter, compared to the consensus estimate of $579.34 million. Amedisys had a return on equity of 12.39% and a net margin of 4.02%. Equities research analysts predict that Amedisys, Inc. will post 4.66 earnings per share for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.